We subsequently developed a more distinct probe, [18F]CFA, which was Employed in The existing research to evaluate dCK action in tumors when handled with a small molecule dCK inhibitor. This probe is also remaining studied inside a medical trial at our institution To judge variations in dCK exercise adhering to cancer immunotherapy 18. PET probes i